Verastem, Inc. Retained Earnings
Verastem, Inc. (VSTM) had Retained Earnings of -$1.24 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$1.24B.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$1.20B.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$1.16B.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$1.13B.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$1.24B 10-Q · filed 2026-08-06 |
| 2026-03-31 | -$1.20B 10-Q · filed 2026-05-07 |
| 2025-12-31 | -$1.16B 10-Q · filed 2026-08-06 |
| 2025-09-30 | -$1.13B 10-Q · filed 2025-11-04 |
| 2025-06-30 | -$1.03B 10-Q · filed 2025-08-07 |
| 2025-03-31 | -$1.01B 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$955.53M 10-K · filed 2026-03-04 |
| 2024-09-30 | -$890.98M 10-Q · filed 2024-11-06 |
| 2024-06-30 | -$867.01M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$858.75M 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$824.89M 10-K · filed 2025-03-20 |
| 2023-09-30 | -$797.52M 10-Q · filed 2023-11-08 |
| 2023-06-30 | -$777.52M 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$753.24M 10-Q · filed 2023-05-09 |
| 2022-12-31 | -$737.52M 10-K · filed 2024-03-14 |
| 2022-09-30 | -$720.72M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$702.63M 10-Q · filed 2022-08-08 |
| 2022-03-31 | -$680.67M 10-Q · filed 2022-05-09 |
| 2021-12-31 | -$663.71M 10-K · filed 2023-03-14 |
| 2021-09-30 | -$647.23M 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$624.44M 10-Q · filed 2021-08-02 |
| 2021-03-31 | -$607.54M 10-Q · filed 2021-05-11 |
| 2020-12-31 | -$592.51M 10-K · filed 2022-03-28 |
| 2020-09-30 | -$572.65M 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$585.78M 10-Q · filed 2020-08-10 |
| 2020-03-31 | -$562.77M 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$524.78M 10-K · filed 2021-03-18 |
| 2019-09-30 | -$486.01M 10-Q · filed 2019-10-30 |
| 2019-06-30 | -$455.87M 10-Q · filed 2019-08-01 |
| 2019-03-31 | -$413.68M 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$375.58M 10-K · filed 2020-03-11 |
| 2018-09-30 | -$364.23M 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$342.56M 10-Q · filed 2018-08-08 |
| 2018-03-31 | -$324.19M 10-Q · filed 2018-05-03 |
| 2017-12-31 | -$303.14M 10-K · filed 2019-03-12 |
| 2017-09-30 | -$284.91M 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$261.78M 10-Q · filed 2017-08-08 |
| 2017-03-31 | -$248.34M 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$235.32M 10-K · filed 2018-03-13 |
| 2016-09-30 | -$223.67M 10-Q · filed 2016-11-07 |
| 2016-06-30 | -$215.75M 10-Q · filed 2016-08-08 |
| 2016-03-31 | -$207.18M 10-Q · filed 2016-05-09 |
| 2015-12-31 | -$198.88M 10-K · filed 2017-03-23 |
| 2015-09-30 | -$187.02M 10-Q · filed 2015-11-09 |
| 2015-06-30 | -$171.57M 10-Q · filed 2015-08-10 |
| 2015-03-31 | -$156.20M 10-Q · filed 2015-05-11 |
| 2014-12-31 | -$141.02M 10-K · filed 2016-03-03 |
| 2014-09-30 | -$127.07M 10-Q · filed 2014-10-30 |
| 2014-06-30 | -$113.74M 10-Q · filed 2014-08-07 |
| 2014-03-31 | -$100.72M 10-Q · filed 2014-05-08 |
| 2013-12-31 | -$87.65M 10-K · filed 2015-03-10 |
| 2013-09-30 | -$76.33M 10-Q · filed 2013-11-12 |
| 2013-06-30 | -$65.74M 10-Q · filed 2013-08-13 |
| 2013-03-31 | -$55.49M 10-Q · filed 2013-05-09 |
| 2012-12-31 | -$46.45M 10-K · filed 2014-03-06 |
| 2012-09-30 | -$38.53M 10-Q · filed 2012-11-13 |
| 2012-06-30 | -$28.16M 10-Q · filed 2012-08-13 |
| 2012-03-31 | -$21.34M 10-Q · filed 2012-05-14 |
| 2011-12-31 | -$14.47M 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |